Advertisement
Advertisement

PHIO

PHIO logo

Phio Pharmaceuticals Corp. Common Stock

0.93
USD
Sponsored
+0.07
+8.08%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

0.90

-0.03
-2.81%

PHIO Earnings Reports

Positive Surprise Ratio

PHIO beat 23 of 29 last estimates.

79%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.34
Implied change from Q3 25 (Revenue/ EPS)
--
/
-22.73%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-60.00%

Phio Pharmaceuticals Corp. Common Stock earnings per share and revenue

On Nov 13, 2025, PHIO reported earnings of -0.44 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 4.14% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an decrease of -22.73% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Phio Pharmaceuticals Corp. Common Stock reported EPS of -$0.44, beating estimates by 4.14%, and revenue of $0.00, 0% as expectations.
The stock price moved down -9.09%, changed from $1.43 before the earnings release to $1.30 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 4 analysts, Phio Pharmaceuticals Corp. Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement